Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies Grant US-11767362-B1 United States of America 26 Sep 2023
DOSAGE REGIMEN FOR COMBINATION THERAPY USING PD-1 AXIS BINDING ANTAGONISTS AND GPC3… Application WO-2019059411-A1 World Intellectual Property Organisation (WIPO) 28 Mar 2019